News & Media / Newsroom
About 15 million euros invested, more than 1,050 square meters, 30 percent of spaces upgraded.
Ribbon cutting took place in the presence of Governor Marsilio
The acquisition process, already announced last August, was completed on schedule and marks the beginning of the integration process of the two companies.
Alfasigma steadies its leadership in the gastrointestinal area and in the research on microbiota by aiming to expand its presence in the international market.
In alignment with our strategic development plan, we are pleased to announce that the new subsidiary Alfasigma Deutschland GmbH with headquarter in Munich is operative, starting from 1st October 2022.
Virtus Alfasigma Tournament and Race For The Cure. Double events that saw the people of Alfasigma engaged in a weekend dedicated to youth, wellness and prevention.
CARNITENE®[1] (L-carnitine), the blockbuster product of Alfasigma Group, was approved for marketing in China in the early 21stcentury. Since July 1, the right to distribute the product in China has been held by Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd.
SOFAR is an Italian company specializing in pharmaceutical products, food supplements and medical devices.
Alfasigma consolidates its leadership in the gastrointestinal area and the research focus on the microbiota.
The acquisition is expected to be completed in October 2022.
[email protected]
+39.051.6489.562
+39.051.6489.884
+39.06.9139.4396
You’re entering Alfasigma global website
I agree